Brainsway Financials
| BWAY Stock | ILA 1,761 34.00 1.89% |
Brainsway |
Understanding current and past Brainsway Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Brainsway's financial statements are interrelated, with each one affecting the others. For example, an increase in Brainsway's assets may result in an increase in income on the income statement.
Please note, the presentation of Brainsway's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Brainsway's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Brainsway's management manipulating its earnings.
Brainsway Stock Summary
Brainsway competes with Intercure, Bio View, and Endymed. Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. BRAINSWAY operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 100 people.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0011007189 |
| Business Address | 19 Hartum Street, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.brainsway.com |
| Phone | (972) 2 582 4030 |
| Currency | ILA |
You should never invest in Brainsway without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Brainsway Stock, because this is throwing your money away. Analyzing the key information contained in Brainsway's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Brainsway Key Financial Ratios
Brainsway's financial ratios allow both analysts and investors to convert raw data from Brainsway's financial statements into concise, actionable information that can be used to evaluate the performance of Brainsway over time and compare it to other companies across industries.| Return On Equity | -0.2 | |||
| Return On Asset | -0.0751 | |||
| Target Price | 14.0 | |||
| Number Of Employees | 118 | |||
| Beta | 0.2 |
Brainsway Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Brainsway's current stock value. Our valuation model uses many indicators to compare Brainsway value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brainsway competition to find correlations between indicators driving Brainsway's intrinsic value. More Info.Brainsway is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Brainsway by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Brainsway's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Brainsway Systematic Risk
Brainsway's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Brainsway volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Brainsway correlated with the market. If Beta is less than 0 Brainsway generally moves in the opposite direction as compared to the market. If Brainsway Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Brainsway is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Brainsway is generally in the same direction as the market. If Beta > 1 Brainsway moves generally in the same direction as, but more than the movement of the benchmark.
Brainsway November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Brainsway help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Brainsway. We use our internally-developed statistical techniques to arrive at the intrinsic value of Brainsway based on widely used predictive technical indicators. In general, we focus on analyzing Brainsway Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Brainsway's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.61 | |||
| Information Ratio | 0.1045 | |||
| Maximum Drawdown | 23.11 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 6.92 |
Complementary Tools for Brainsway Stock analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |